For Doctors in a Hurry
- Researchers investigated whether a multicomponent intervention could reduce maternal sepsis mortality and morbidity caused by inconsistent implementation of infection prevention guidelines.
- This cluster-randomized trial evaluated 59 health facilities in Malawi and Uganda, involving 431,394 women who gave birth during the study.
- The primary outcome occurred in 1.4% of intervention patients versus 1.9% in usual care (risk ratio 0.68; 95% CI, 0.55-0.83; P<0.001).
- The researchers concluded that the APT-Sepsis program significantly reduced the composite risk of infection-related maternal death, near-miss events, or severe illness.
- Implementing standardized protocols for early sepsis detection and treatment bundles may effectively lower maternal morbidity in resource-limited clinical settings.
Mitigating the Global Burden of Maternal Sepsis
Maternal sepsis and severe infection remain leading causes of preventable mortality and morbidity worldwide, particularly in resource-limited healthcare systems [1, 2]. While international guidelines emphasize early identification and immediate resuscitation, inconsistent implementation of these evidence-based practices often leads to critical delays in care [3, 4]. Multimodal strategies that integrate education, protocol adherence, and standardized treatment bundles have shown success in reducing surgical site infections and improving neonatal outcomes in Sub-Saharan Africa [5, 6, 7]. However, bridging the gap between clinical recommendations and routine practice requires robust implementation frameworks that address organizational barriers and facilitate frontline engagement [8, 9]. To address this gap, researchers recently conducted a large-scale cluster-randomized trial to evaluate a comprehensive program designed to standardize maternal infection prevention and sepsis management.
The APT-Sepsis Implementation Framework
The Active Prevention and Treatment of Maternal Sepsis (APT-Sepsis) program is a multicomponent intervention designed to support health care providers in the systematic application of evidence-based protocols. Unlike traditional educational outreach, this program focuses on three specific clinical goals to reduce the incidence of severe infection. First, the framework emphasizes strict adherence to World Health Organization (WHO) hand-hygiene standards to minimize the introduction of pathogens during clinical procedures. Second, it promotes the adoption of evidence-based practices for maternal infection prevention and management, ensuring that prophylactic measures are applied consistently across the obstetric care continuum. Third, the program prioritizes early sepsis detection, training clinicians to identify the physiological triggers of systemic infection before they progress to life-threatening organ dysfunction.
Central to the intervention is the use of the FAST-M treatment bundle, a structured clinical tool designed to streamline the initial management of suspected sepsis. The bundle consists of five critical components: fluids for hemodynamic resuscitation, antibiotics administered within the first hour of recognition, source control to remove the focus of infection, transfer if required to a higher level of care, and continuous monitoring of maternal vital signs. This standardized approach was evaluated against a control group that received usual care, which included the dissemination of clinical guidelines without the structured implementation support provided by the APT-Sepsis framework. For practicing obstetricians and frontline clinicians, this structured bundle offers a practical method to overcome the implementation gaps that often lead to preventable maternal mortality.
Trial Design and Patient Population
The researchers evaluated the APT-Sepsis program through a large-scale cluster-randomized trial (a study design where entire facilities, rather than individual patients, are randomized to an intervention) conducted across 59 health facilities in Malawi and Uganda. To ensure a robust comparison between the intervention and standard practices, the study randomly assigned these facilities into two groups. Specifically, 30 clusters received the multicomponent APT-Sepsis program, while 29 clusters continued with usual care, which included the standard dissemination of clinical guidelines. The study population comprised women who were pregnant or had recently been pregnant, representing a total of 431,394 women who gave birth at the participating facilities during the trial period. This substantial sample size provided the statistical power necessary to detect meaningful differences in maternal outcomes across diverse clinical settings, ranging from small health centers to larger referral hospitals.
The primary outcome of the trial was a composite measure designed to capture the full spectrum of maternal morbidity and mortality. This composite included infection-related maternal death, infection-related near-miss events (instances where women survived a life-threatening complication), and severe infection-related illness. The researchers defined severe infection-related illness specifically as deep surgical-site infections, deep perineal infections, or body-cavity infections. By tracking these specific clinical markers, the study aimed to quantify the program's impact on preventing the progression of localized infections into systemic, life-threatening conditions. The trial received financial support from the Joint Global Health Trials scheme and other funding partners to address the critical need for standardized sepsis management in resource-limited environments.
Significant Reductions in Severe Maternal Outcomes
The trial results demonstrated that the APT-Sepsis program significantly reduced the incidence of the primary composite outcome, which included infection-related maternal death, near-miss events, and severe illness. Among the women in the intervention group, a primary-outcome event occurred in 1.4% of patients, compared to 1.9% of patients in the usual-care group. This difference represents a risk ratio of 0.68 (95% confidence interval, 0.55 to 0.83; P<0.001). These findings address a critical global health challenge, as maternal infection and sepsis remain major causes of maternal death and severe illness worldwide, particularly in low- and middle-income countries. By standardizing care, the program targets the inconsistent implementation of evidence-based recommendations for infection prevention and management that currently contributes to the high number of preventable deaths in these regions.
The clinical impact of the intervention was not limited to specific settings. The treatment effect was generally consistent between Malawi and Uganda and remained consistent among facilities of different sizes, from small clinics to larger hospitals. Furthermore, the reduction in risk was sustained over the course of the trial, suggesting that the program's protocols can be integrated into long-term clinical practice. For practicing physicians, these results underscore the value of structured clinical pathways. Because delays in the detection and treatment of maternal sepsis contribute significantly to preventable mortality, closing the gap between evidence-based guidelines and bedside practice directly mitigates the risks associated with late identification and inconsistent management of maternal infections.
References
1. Lissauer D, Gadama L, Waitt C, et al. A Multicomponent Intervention to Improve Maternal Infection Outcomes. New England Journal of Medicine. 2025. doi:10.1056/nejmoa2512698
2. Lissauer D, Gadama L, Waitt C, et al. A Multicomponent Intervention to Improve Maternal Infection Outcomes.. The New England journal of medicine. 2026. doi:10.1056/NEJMoa2512698
3. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine. 2021. doi:10.1097/ccm.0000000000005337
4. Karamagi H, Berhane A, Kidane SN, et al. High impact health service interventions for attainment of UHC in Africa: A systematic review. PLOS Global Public Health. 2022. doi:10.1371/journal.pgph.0000945
5. Berhe F, Belachew T, Hassen K. Effect of interventions on surgical site infections in Sub-Saharan Africa: a systematic review. BMC Surgery. 2025. doi:10.1186/s12893-025-02946-1
6. Alemán A, Tomasso G, Cafferata ML, Colomar M, Betrán AP. Supply kits for antenatal and childbirth care: a systematic review. Reproductive Health. 2017. doi:10.1186/s12978-017-0436-9
7. Gan A, Khursheed R, Savanur M, Dalal A, Maldar A. The Impact of an Evidence-Based Bundle on Cesarean Section-Related Surgical Site Infections: A Randomized Clinical Trial. Maternal-Fetal Medicine. 2024. doi:10.1097/fm9.0000000000000220
8. Iroz CB, Ramaswamy R, Bhutta ZA, Barach P. Quality improvement in public–private partnerships in low- and middle-income countries: a systematic review. BMC Health Services Research. 2024. doi:10.1186/s12913-024-10802-w
9. Nyantakyi E, Baenziger J, Caci L, et al. Investigating the implementation of infection prevention and control practices in neonatal care across country income levels: a systematic review. Antimicrobial Resistance and Infection Control. 2025. doi:10.1186/s13756-025-01516-7
